Nature. 1966 Dec 31;212(5070):1542-4. doi: 10.1038/2121542a0 Q148.52025
I-adamantanamine hydrochloride prophylaxis for experimentally induced A/equine 2 influenza virus infection
氯化伊-金刚烷胺预防实验性马2型流感病毒感染 翻译改进
J T Bryans 1, W W Zent, R R Grunert, D C Boughton
作者单位 +展开
作者单位
DOI: 10.1038/2121542a0 PMID: 21105501
摘要 中英对照阅读
相关内容
-
Protection of volunteers against challenge with A-Hong Kong-68 influenza virus by a new adamantane compound
一种新型adamantane化合物对志愿者甲型香港68流感病毒攻击的保护作用
A S Beare
Lancet (London, England). 1972 May 13;1(7759):1039-40.
-
Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers
志愿者预防鼻病毒和流感病毒的鼻内淋巴母细胞干扰素("Wellferon")防护作用
R J Phillpotts et al.
Journal of interferon research. 1984 Fall;4(4):535-41.
-
[The antiviral activity of the adamantane derivatives against the influenza virus A (H1N1) pdm2009 model in vivo]
金刚烷胺类衍生物抗H1N1甲型流感病毒体内活性研究
M Iu Shchelkanov et al.
Voprosy virusologii. 2014 Mar-Apr;59(2):37-40.
-
Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel
研究/综述:甲型流感病毒M2质子通道耐胺类药物突变的结构及连锁不平衡分析
Yao Yu et al.
Current drug metabolism. 2014;15(5):526-34.
-
Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein
adamantane胺类衍生物和天然多胺通过不同抑制模式对重组流感病毒M2蛋白的抑制作用研究
T I Lin
The Journal of general virology. 1997 Apr:78 ( Pt 4):767-74.
-
Limitations of current prophylaxis against influenza virus infection
当前预防流感病毒感染的局限性
Mario Guralnik et al.
American journal of therapeutics. 2007 Sep-Oct;14(5):449-54.
-
Antiviral treatment and prophylaxis of influenza virus in children
儿童流感病毒的治疗和预防措施
Jennifer L Nayak
Pediatric annals. 2009 Dec;38(12):667-74.
-
Assessment of Anti-Influenza Drug Prescriptions for Postexposure Prophylaxis Against Household Transmission of Influenza Virus
评估针对预防流感病毒家庭内传播的抗流感药物术后预防性处方的状况
Masahiro Shirata
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Oct 5;73(7):e1766.